65 Equity Partners-backed Tamarind Health offers to privatize Singapore healthcare firm TalkMed
Tamarind Health, a Singapore-based pan-Asian oncology-focused group backed by investors including Temasek unit 65 Equity Partners, is offering S$0.456 ($0.34) per share to privatize cancer specialist TalkMed Group. TalkMed said in a statement on Monday that the offeror intends to delist and privatize TalkMed. According to the statement, the transaction is expected to improve patient care by...
0 評論 0 分享 834 瀏覽量 0 Reviews
贊助
贊助